Abstract:Objectives Although elevated levels of neutrophil extracellular traps (NETs) have been reported in patients with rheumatoid arthritis (RA), the role of NETs in RA and the relationship between NETs and macrophages in the pathogenesis of RA requires further research. Here, we sought to determine the role of NETs in RA pathogenesis and reveal the potential mechanism. Methods Neutrophil elastase (NE) and myeloperoxidase (MPO)-DNA were measured in human serum and synovium. NETs inhibitor GSK484 was used to examine whether NETs involved with RA progression. We stimulated macrophages with NETs and detected internalisation-related proteins to investigate whether NETs entry into macrophages and induced inflammatory cytokines secretion through internalisation. To reveal mechanisms mediating NETs-induced inflammation aggravation, we silenced GTPases involved in internalisation and inflammatory pathways in vivo and in vitro and detected downstream inflammatory pathways. Results Serum and synovium from patients with RA showed a significant increase in NE and MPO, which positively correlated to disease activity. Inhibiting NETs formation alleviated the collagen-induced arthritis severity. In vitro, NETs are internalised by macrophages and located in early endosomes. Rab 5a was identified as the key mediator of the NETs internalisation and inflammatory cytokines secretion. Rab 5a knockout mice exhibited arthritis alleviation. Moreover, we found that NE contained in NETs activated the Rab5a-nuclear factor kappa B (NF-B) signal pathway and promoted the inflammatory cytokines secretion in macrophages. Conclusions This study demonstrated that NETs-induced macrophages inflammation to aggravate RA in Rab 5a dependent manner. Mechanically, Rab5a mediated internalisation of NETs by macrophages and NE contained in NETs promoted macrophages inflammatory cytokines secretion through NF-B-light-chain-enhancer of activated B cells signal pathway. Therapeutic targeting Rab 5a or NE might extend novel strategies to minimise inflammation in RA.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the role of neutrophil extracellular traps (NETs) in the pathogenesis of rheumatoid arthritis (RA) and its relationship with macrophages. Specifically, the study aims to determine the role of NETs in the pathological process of RA and reveal its underlying mechanisms. Researchers explored whether NETs are involved in the development of RA by detecting the levels of neutrophil elastase (NE) and myeloperoxidase (MPO) in the serum and synovial tissue of patients, and using the NETs inhibitor GSK484. In addition, the study also explored how NETs induce the secretion of inflammatory cytokines after being endocytosed by macrophages, especially through the Rab5a - mediated endocytosis pathway, and further studied the crucial role played by Rab5a in this process. The main findings of the study include: - The levels of NE and MPO in the serum and synovium of RA patients are significantly increased and are positively correlated with disease activity. - Inhibiting the formation of NETs can alleviate the severity of collagen - induced arthritis. - In in - vitro experiments, NETs are endocytosed by macrophages and are located in early vesicles. Rab5a is identified as a key mediator of NETs endocytosis and inflammatory cytokine secretion. - Mice with Rab5a knocked out show alleviation of arthritis symptoms. - The study also found that NE in NETs activates the Rab5a - nuclear factor κB (NF - κB) signaling pathway, promoting the secretion of inflammatory cytokines in macrophages. These findings indicate that NETs induce macrophage inflammation in a Rab5a - dependent manner, thereby exacerbating RA. Mechanistically, Rab5a mediates the endocytosis of NETs, and NE in NETs promotes the secretion of inflammatory cytokines through the NF - κB signaling pathway. Therefore, targeting Rab5a or NE may be a new strategy for reducing RA inflammation.

Internalisation of neutrophils extracellular traps by macrophages aggravate rheumatoid arthritis via Rab5a